427 related articles for article (PubMed ID: 24574230)
1. Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: a new model of systemic Lupus erythematosus.
Yokogawa M; Takaishi M; Nakajima K; Kamijima R; Fujimoto C; Kataoka S; Terada Y; Sano S
Arthritis Rheumatol; 2014 Mar; 66(3):694-706. PubMed ID: 24574230
[TBL] [Abstract][Full Text] [Related]
2. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
[TBL] [Abstract][Full Text] [Related]
3. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
[TBL] [Abstract][Full Text] [Related]
4. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.
Savarese E; Steinberg C; Pawar RD; Reindl W; Akira S; Anders HJ; Krug A
Arthritis Rheum; 2008 Apr; 58(4):1107-15. PubMed ID: 18383384
[TBL] [Abstract][Full Text] [Related]
5. Sialic acid-binding immunoglobulin-type lectin H-positive plasmacytoid dendritic cells drive spontaneous lupus-like disease development in B6.Nba2 mice.
Davison LM; Jørgensen TN
Arthritis Rheumatol; 2015 Apr; 67(4):1012-22. PubMed ID: 25504931
[TBL] [Abstract][Full Text] [Related]
6. IgE Inhibits Toll-like Receptor 7- and Toll-like Receptor 9-Mediated Expression of Interferon-α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
Khoryati L; Augusto JF; Shipley E; Contin-Bordes C; Douchet I; Mitrovic S; Truchetet ME; Lazaro E; Duffau P; Couzi L; Jacquemin C; Barnetche T; Vacher P; Schaeverbeke T; Blanco P; Richez C;
Arthritis Rheumatol; 2016 Sep; 68(9):2221-31. PubMed ID: 26991804
[TBL] [Abstract][Full Text] [Related]
7. Editorial: toll-like receptor 7: more than skin deep?
Elkon KB; Sontheimer C
Arthritis Rheumatol; 2014 Mar; 66(3):481-4. PubMed ID: 24574205
[No Abstract] [Full Text] [Related]
8. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE
Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347
[TBL] [Abstract][Full Text] [Related]
9. Ligands to nucleic acid-specific toll-like receptors and the onset of lupus nephritis.
Pawar RD; Patole PS; Ellwart A; Lech M; Segerer S; Schlondorff D; Anders HJ
J Am Soc Nephrol; 2006 Dec; 17(12):3365-73. PubMed ID: 17082246
[TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus.
Sacre K; Criswell LA; McCune JM
Arthritis Res Ther; 2012 Jun; 14(3):R155. PubMed ID: 22734582
[TBL] [Abstract][Full Text] [Related]
11. Integrin αvβ3 Limits Cytokine Production by Plasmacytoid Dendritic Cells and Restricts TLR-Driven Autoimmunity.
Lorant AK; Yoshida AE; Gilbertson EA; Chu T; Stefani C; Acharya M; Hamerman JA; Lacy-Hulbert A
J Immunol; 2024 Jun; 212(11):1680-1692. PubMed ID: 38607278
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus.
Pawar RD; Ramanjaneyulu A; Kulkarni OP; Lech M; Segerer S; Anders HJ
J Am Soc Nephrol; 2007 Jun; 18(6):1721-31. PubMed ID: 17460144
[TBL] [Abstract][Full Text] [Related]
13. Pin1-Targeted Therapy for Systemic Lupus Erythematosus.
Wei S; Yoshida N; Finn G; Kozono S; Nechama M; Kyttaris VC; Zhen Zhou X; Tsokos GC; Ping Lu K
Arthritis Rheumatol; 2016 Oct; 68(10):2503-13. PubMed ID: 27159270
[TBL] [Abstract][Full Text] [Related]
14. Using Poly I:C as an adjuvant does not induce or exacerbate models of systemic lupus erythematosus.
Annable T; Tomassian T; Jain S; Leibbrandt M; Cooke MP; Deane JA
Autoimmunity; 2015 Feb; 48(1):29-39. PubMed ID: 25483245
[TBL] [Abstract][Full Text] [Related]
15. Topical imiquimod treatment prevents UV-light induced loss of contact hypersensitivity and immune tolerance.
Thatcher TH; Luzina I; Fishelevich R; Tomai MA; Miller RL; Gaspari AA
J Invest Dermatol; 2006 Apr; 126(4):821-31. PubMed ID: 16439962
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 8 deletion accelerates autoimmunity in a mouse model of lupus through a Toll-like receptor 7-dependent mechanism.
Tran NL; Manzin-Lorenzi C; Santiago-Raber ML
Immunology; 2015 May; 145(1):60-70. PubMed ID: 25424423
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 7-stimulated tumor necrosis factor α causes bone marrow damage in systemic lupus erythematosus.
Zhuang H; Han S; Xu Y; Li Y; Wang H; Yang LJ; Reeves WH
Arthritis Rheumatol; 2014 Jan; 66(1):140-51. PubMed ID: 24449581
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Modulation of Plasmacytoid Dendritic Cells in Experimental Arthritis.
Nehmar R; Alsaleh G; Voisin B; Flacher V; Mariotte A; Saferding V; Puchner A; Niederreiter B; Vandamme T; Schabbauer G; Kastner P; Chan S; Kirstetter P; Holcmann M; Mueller C; Sibilia J; Bahram S; Blüml S; Georgel P
Arthritis Rheumatol; 2017 Nov; 69(11):2124-2135. PubMed ID: 28777892
[TBL] [Abstract][Full Text] [Related]
19. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 7/8 agonists stimulate plasmacytoid dendritic cells to initiate T
Garzorz-Stark N; Lauffer F; Krause L; Thomas J; Atenhan A; Franz R; Roenneberg S; Boehner A; Jargosch M; Batra R; Mueller NS; Haak S; Groß C; Groß O; Traidl-Hoffmann C; Theis FJ; Schmidt-Weber CB; Biedermann T; Eyerich S; Eyerich K
J Allergy Clin Immunol; 2018 Apr; 141(4):1320-1333.e11. PubMed ID: 28935206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
